Evidence map›Paper›PMID 38435139›Full record

ArticleCureus2024

The Use of Herbal Medicines Among Cancer Patients.

Ana Carolina Vasques, Patricia Cavaco, Tânia Duarte, Vanessa Duarte Branco, Mafalda Miranda Baleiras, Marta Pinto, Filipa Ferreira, Maria de Fátima Falcão, Tiago Dias Domingues, Ana Martins

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ana Carolina VasquesMedical Oncology, Centro Hospitalar Lisboa Ocidental, Lisbon, PRT.
Patricia CavacoHospital Pharmacy, Centro Hospitalar Lisboa Ocidental, Lisbon, PRT.
Tânia DuarteMedical Oncology, Centro Hospitalar Lisboa Ocidental, Lisbon, PRT.
Vanessa Duarte BrancoMedical Oncology, Centro Hospitalar Lisboa Ocidental, Lisbon, PRT.
Mafalda Miranda BaleirasMedical Oncology, Centro Hospitalar Lisboa Ocidental, Lisbon, PRT.
Marta PintoMedical Oncology, Centro Hospitalar Lisboa Ocidental, Lisbon, PRT.
Filipa FerreiraMedical Oncology, Centro Hospitalar Lisboa Ocidental, Lisbon, PRT.
Maria de Fátima FalcãoHospital Pharmacy, Centro Hospitalar Lisboa Ocidental, Lisbon, PRT.
Tiago Dias DominguesStatistics and Operations Research, Faculty of Sciences of the University of Lisbon, Lisbon, PRT.
Ana MartinsMedical Oncology, Centro Hospitalar Lisboa Ocidental, Lisbon, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective The use of herbal medicines has been increasing among cancer patients, as a way to control cancer and treatment-related symptoms; however, many patients are reluctant to disclose this use to their medical practitioners. The fact that oncological treatments have a narrow therapeutic margin, associated with the lack of control and clinical evidence concerning these supplements, makes medication-herbal interactions a reality. These interactions could lead to increased toxicity or a decreased effectiveness of oncological treatment. In light of this, we aimed to assess the prevalence of herbal medicine use in a patient population at a Portuguese central hospital: Centro Hospitalar Lisboa Ocidental. Materials and methods Patients with breast, prostate, or colorectal cancer diagnoses between August 2022 and July 2023 and undergoing oncological treatment were included. Data were collected through a survey during their first appointment, as well as by consulting the patients' clinical files. An interaction evaluation was carried out to assess potential medication-herbal interactions. Finally, a statistical analysis was performed to identify predictive factors for the use of herbal medicines. Results Among the 65 patients included in the study, 52% were females, and the median age of the cohort was 65 years. Breast cancer was the most prevalent diagnosis and the majority of the patients were undergoing palliative treatment. We found that 46% of patients used herbal medicines regularly: to strengthen the immune system, detoxification of the body, and treat insomnia and constipation. A medication-herbal interaction was found in 37% of the cases, the most frequent being doxorubicin-vitamin C, through an antioxidant mechanism. The univariable analysis failed to show any predictive factors associated with the use of herbal medicines. Conclusions This study sheds light on herbal medicine use among cancer patients and the reality of medication-herbal interactions. There is an urgent need for further research and evidence-based medical protocols regarding herbal medicine use, especially in complex cases such as cancer patients, to provide better and safer care.

Indexed as

adverse effectscancer patientsherbal medicineinteractionspharmacokinetics

Identifiers

PMID38435139
PMCPMC10909387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.